Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.
about
Screening for prostate cancerScreening for prostate cancerThe story of the European Randomized Study of Screening for Prostate Cancer.Nonlinear modeling was applied thoughtfully for risk prediction: the Prostate Biopsy Collaborative Group.Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.Variations in prostate biopsy practice: A quantitative questionnaire-based studySmarter screening for prostate cancer: for the few, not the many? A stratified approach based on baseline risk.Biomarker development, from bench to bedside.A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.On-chip screening for prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA.Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.Actual Contribution of Free to Total PSA Ratio in Prostate Diseases Differentiation.The establishment and evaluation of a new model for the prediction of prostate cancer.Correlation of transrectal ultrasonographic findings with histo pathology in prostatic cancer.The Finnish trial of prostate cancer screening: where are we now?Tumour Markers: Rationale Use.
P2860
Q24201690-D2ABD562-A572-4709-8DAA-6E0C01BB9864Q24245476-33EB10F9-E23C-4AD9-B384-548380D1B3C4Q35675436-26832656-A7C2-4702-8F9D-73C3CFA1D25DQ35760036-7E3B5B39-360B-401D-A724-E3EE313CA46DQ37252155-44CFC030-F60A-4FED-A2AD-BA219709DD48Q37342953-58B733E8-014B-41ED-89DD-9193E211524FQ37845825-733DE0E5-0443-4FFC-A02B-0E53AAE28646Q38569348-78232931-6DE9-45C5-A4BA-088E5A3CC1BFQ39213559-9D426CCA-74AC-4CE2-9002-C4A405033363Q39378788-34376E26-F66A-4A5D-BEE6-703C78CAEEA7Q40181136-34D2BC3E-4F41-4BAC-B36F-0B6784109CB7Q41170515-4AFB19CA-FA5C-480D-B9CD-ADEBCAB09F66Q41820762-2D29D1A0-FB94-4B49-BFF8-7E962B9B0736Q42141452-EDB884F7-C63B-4354-9641-7E81BD8BC7C7Q43484941-2F49CE31-29B8-4D75-A00E-37326BC4399AQ55252785-ABFB5730-378D-4265-BFDE-F46B835382AD
P2860
Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Estimation of prostate cancer ...... nd digital rectal examination.
@en
Estimation of prostate cancer ...... nd digital rectal examination.
@nl
type
label
Estimation of prostate cancer ...... nd digital rectal examination.
@en
Estimation of prostate cancer ...... nd digital rectal examination.
@nl
prefLabel
Estimation of prostate cancer ...... nd digital rectal examination.
@en
Estimation of prostate cancer ...... nd digital rectal examination.
@nl
P2093
P1433
P1476
Estimation of prostate cancer ...... nd digital rectal examination.
@en
P2093
Harri Juusela
Liisa Määttänen
Matti Hakama
Patrik Finne
Sakari Rannikko
Teuvo L J Tammela
P304
619-26; discussion 626-7
P356
10.1016/S0302-2838(02)00179-3
P407
P577
2002-06-01T00:00:00Z